David is an expert in molecular modeling and simulation with over 8 years of postdoctoral experience at University College London researching the use of modeling and simulation in complex biological systems and applying this to systems that can better predict resistance to small molecule cancer drugs.
Since 2017 David has had senior technology leadership experience in AI biotech companies and co-founded Kuano in 2020.
David holds a PhD in Chemistry from University College London.
Sign up to view 0 direct reports
Get started